Tourmaline Bio, Inc. (TRML)
NASDAQ: TRML · Real-Time Price · USD
24.00
+0.50 (2.13%)
Nov 20, 2024, 4:00 PM EST - Market closed
Tourmaline Bio Market Cap
Tourmaline Bio has a market cap or net worth of $609.01 million as of November 21, 2024. Its market cap has increased by 92.95% in one year.
Market Cap
609.01M
Enterprise Value
333.79M
1-Year Change
92.95%
Ranking
Category
Stock Price
$23.75
Market Cap Chart
Since October 20, 2023, Tourmaline Bio's market cap has increased from $221.67M to $609.01M, an increase of 174.74%. That is a compound annual growth rate of 153.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 615.42M | 15.59% |
| Dec 29, 2023 | 532.42M | 140.18% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| agilon health | 648.93M |
| IRADIMED CORPORATION | 646.35M |
| Definitive Healthcare | 645.23M |
| Oculis Holding AG | 639.66M |
| EyePoint Pharmaceuticals | 637.05M |
| Entrada Therapeutics | 628.27M |
| Ironwood Pharmaceuticals | 626.51M |
| Exscientia | 624.21M |